Zurueck zur Suche

Reporte zur Charge UJ888AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

17Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CO 3 AZ 3 TX 3 NJ 2 MA 1 WA 1 LA 1 CA 1 FL 1

VAERS 2486189

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj888aa

schwer
Staat
CO
Alter
19,0
Geschlecht
F
Eingang
21.10.2022
Impfdatum
21.10.2022
Beginn
21.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Patient collapsed shortly after given vaccination; has a history of syncope due to needle phobia and stated that this has happened in the past during blood draws. EMS was called and patient had normal vitals upon being checked. Epinephrine was not administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
None
Allergien
PEANUT ALLERGY
Vorherige Impfungen
-

VAERS 2648190

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ888AA

mild
Staat
NJ
Alter
58,0
Geschlecht
F
Eingang
22.06.2023
Impfdatum
-
Beginn
04.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Urticaria

Symptomtext

Her shoulder and deltoid became red; Her shoulder and deltoid became red and welted; the welt measures about 10x 10 cm; Initial information received on 05-Oct-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case involves a 58-year-old female patient whose shoulder and deltoid became red and welted; the welt measures about 10x 10 cm while receiving vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (strength, formulation, dose, route, frequency: unknown) (lot number: UJ888AA and expiry date: 09-Jun-2023) in unknown administration site for Immunization. On 04-Oct-2022, the patient developed non-serious events of, her shoulder and deltoid became red (erythema) and welted; the welt measures about 10x 10 cm (urticaria) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. It was reported, she has the LOT and EXP for a product but is not sure what the product name is. Reporter mentioned that the product does not contain any egg which would make the product the FLUBLOK vaccine. Caller mentioned that an employee had a reaction to a preservative containing flu product last year, unknown which product manufacturer, and would like to know if the flu product they currently have has any preservative in it. Reported, that the employee received the product on 4Oct2022 and developed a localized reaction. It has not spread or gotten any worse. Caller also asked what other flu products if any does? She would like to know if a patient is greater than 50 years old which product should they receive? She would like to know if any other of the flu products are a preservative free product? Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK) was not applicable. Corrective treatment: They are putting warm compresses for the events. At time of reporting, the outcome was Unknown for both events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2590877

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

mild
Staat
MA
Alter
40,0
Geschlecht
F
Eingang
03.03.2023
Impfdatum
01.03.2023
Beginn
01.03.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain upper Hypersensitivity Myalgia Pain Rash Rash pruritic

Symptomtext

Per patient email report: "I woke up last night with a severe, cramping stomachache, along with muscle/body aches that is not improving with ibuprofen and Tums. I am also developing a very itchy rash/allergic reaction on the sides of my abdomen. "

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Patient indicated she has received the flu shot in previous years (most likely NOT Flubloc) and has always suffered body aches/f

VAERS 2533385

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

mild
Staat
AZ
Alter
58,0
Geschlecht
M
Eingang
15.12.2022
Impfdatum
10.12.2022
Beginn
12.12.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Pyrexia SARS-CoV-2 test negative

Symptomtext

PATIENT CALLED BACK ON 12/15/22 EXPRESSING CONCERNS WITH HAVING ADVERSE EFFECTS (INCULING FEVER AND COUGH) 2 DAYS FOLLOWOING RECEIVING HIS FLU VACCINES. NO PCR OR FLU TEST HAS BEEN DONE.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
AT HOME COVID TEST RESULTS WERE NEGATIVE.
Aktuelle Erkrankungen
N/A
Vorgeschichte
M/A
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
HE ALWAYS HAD ADVERSE EVENT WITH FLU VACCINES

VAERS 2533199

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj888aa

mild
Staat
AZ
Alter
61,0
Geschlecht
F
Eingang
15.12.2022
Impfdatum
13.12.2022
Beginn
13.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site rash

Symptomtext

Pt described arm as being sore (more sore than what she previously experienced) and about a 3 inch diameter rash around injection site. She showed me the area and it was ~ 2 inches in diameter and slightly red. Pt remarked it had improved from yesterday. I recommended pt contact MD for guidance as to whether antibiotics would be required. Spoke with pt 12/15/22 and pt reports no soreness and redness cleared up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported.
Vorgeschichte
None on file at time of report
Andere Medikamente
Pantoprazole, lisinopril
Allergien
Penicillin, Sulfa
Vorherige Impfungen
-

VAERS 2497922

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj888aa

mild
Staat
AZ
Alter
64,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
01.11.2022
Beginn
02.11.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site rash Rash erythematous Rash papular

Symptomtext

patient developed a 3x3 inch raised red rash on her arm, below the site of the injection

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
high cholesterol
Andere Medikamente
pravastatin
Allergien
none
Vorherige Impfungen
-

VAERS 2493302

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj888aa

mild
Staat
TX
Alter
56,0
Geschlecht
F
Eingang
28.10.2022
Impfdatum
18.10.2022
Beginn
24.10.2022
Tage bis Beginn
6,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash erythematous

Symptomtext

red rash on right arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
diabetes, neuropathic pain
Vorgeschichte
diabetic
Andere Medikamente
glipizide, ferrous sulphate, folic acid, pioglitazone, etodolac, fluocinonide ointment, albuterol inhaler, latanoprost, xigduo, potassium chloride, furosemide, atorvastatin, metoprolol, breo ellipta, metformin, cetirizine, motelukast, lyric
Allergien
no allergies
Vorherige Impfungen
-

VAERS 2478822

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

mild
Staat
WA
Alter
60,0
Geschlecht
F
Eingang
14.10.2022
Impfdatum
13.10.2022
Beginn
14.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Erythema Local reaction Pruritus Skin swelling Skin warm Urticaria

Symptomtext

Large approx. 4-inch red, warm, raised welt. Itchy with no systemic symptoms. Localized at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Synthroid
Allergien
eggs sensitivities
Vorherige Impfungen
-

VAERS 2460654

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

mild
Staat
-
Alter
54,0
Geschlecht
F
Eingang
26.09.2022
Impfdatum
20.09.2022
Beginn
21.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Chills Cough Dysphagia Dysphonia Immunisation reaction Myalgia Oropharyngeal discomfort Oropharyngeal pain Pain Pharyngeal swelling Pyrexia SARS-CoV-2 test negative Streptococcus test negative Throat irritation

Symptomtext

Per pt., "I woke up on Wednesday morning with a very ?scratchy? or funny feeling in my throat. I felt fine otherwise. I woke up on Wednesday night with a very sore throat and had a low grade temp of 99.6, muscle aches. I did a Covid test that was negative and came to work as I suspected this was from the flu vaccine. We were too short staffed to call off sick. I continued with achiness all day and by the time my shift ended, I had chills, muscle aches and fever 101.7 by the time I got home. I continued to wake up at night with a severe sore throat and was difficult to swallow. My temp on Friday was 99.6 and improved by evening. I went to Urgent care as I was concerned that maybe I had strep. I had a total of 3 negative Covid tests at this point. My strep was negative. At urgent care, he said my throat was swollen and gave me viscous lidocaine as I could not swallow. At Urgent care, I was told this was most likely from the vaccine and recommended that I speak to my usual specialists. Urgent care did give me an antibiotic if this did not improve, which I did start ( this was started after my temp was already better). My temp has improved since Friday evening, and sore throat improved on Saturday, but I continue with some hoarseness and dry cough even today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2513681

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ888AA

gering
Staat
LA
Alter
12,0
Geschlecht
M
Eingang
22.11.2022
Impfdatum
12.11.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error No adverse event Product administered to patient of inappropriate age

Symptomtext

Inappropriate age at vaccine administration with no reported adverse event; Initial information received on 14-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 years old male patient who was administration Influenza Quadrivalent Recombinant Vaccine [Flublok] vaccine at inappropriate age. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 12-Nov-2022, the patient received a dose of 0.5 ml dose 1 of suspect Influenza Quadrivalent Recombinant Vaccine (lot UJ888AA) via intramuscular route in the right deltoid (formulation, expiry date, strength was unknown) for immunization that was administration at inappropriate age with no reported adverse event. Action taken was not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2509262

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ888AA

gering
Staat
CA
Alter
61,0
Geschlecht
F
Eingang
16.11.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Expired product administered Medication error No adverse event Syringe issue

Symptomtext

an exposure took place described as due to the vaccine leaking from the syringe the consumer had a lot of fluid to drip down the arm with no adverse event; expired vaccine used with no adverse event; Initial information received on 07-Nov-2022 regarding an unsolicited valid non-serious case from a nurse. This case involves a 61 year old female patient who had an exposure to the INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] leaking from the syringe the consumer had a lot of fluid to drip down the arm with no adverse event and expired vaccine used with no adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. On 20-Oct-2022, the patient received suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE at a dose of 0.5 ml once (lot UJ888AA, expiry date: 09-Jun-2022) via intramuscular route in left arm for Immunization. On 20-Oct-2022, an exposure took place described as due to the vaccine leaking from the syringe the consumer had a lot of fluid to drip down the arm with no adverse event (accidental exposure to product) and expired vaccine used with no adverse event (expired product administered) (same day latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. It was reported When she administered the flu vaccine to the patient and she started to inject, the medicine started to come out of the back of the syringe. Nurse would like to know if she needs to revaccinate because she is not sure how much the patient received. A Nurse reporting a partial dose due to having 1-FLUBLOK syringe to leak from the back of the syringe; that it is unknown to the caller the exact location of the leak; that the syringe has been disposed of in the SHARPS container; that there was no known defect to the syringe or the carton; and that an exposure took place described as due to the vaccine leaking from the syringe the consumer had a lot of fluid to drip down the arm. Action taken: not applicable. Outcome: Unknown for both the events. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2508727

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

gering
Staat
TX
Alter
12,0
Geschlecht
M
Eingang
15.11.2022
Impfdatum
28.10.2022
Beginn
28.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

N/A

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2489614

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ888AA

gering
Staat
NJ
Alter
36,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
18.10.2022
Beginn
18.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy

Symptomtext

12 weeks pregnant got flublok with no reported adverse event; Initial information received on 18-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case is linked to case 2022SA435259(CLUSTER). This case involves a 36 years old female patient who was exposed to vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] in context of 12 weeks pregnant got flublok with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported 12 weeks pregnant got flublok with no reported adverse event occurred at 13 weeks of pregnancy and the patient was exposed to INFLUENZA QUADRIVALENT RECOMBINANT VACCINE at 13 weeks of pregnancy, during first pregnancy trimester for INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. The date of last menstrual period was reported as 27-Jul-2022. The estimated due date is 03-May-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On 18-Oct-2022, the patient received 0.5ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (strength, formulation was unknown, lot UJ888AA and expiry date: 08-Jun-2023) via unknown route in the left deltoid for Immunization. On 18-Oct-2022 the patient developed a non-serious event of 12 weeks pregnant got flublok with no reported adverse event (exposure during pregnancy) (Latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken : not applicable. Outcome: Unknown Additionally, at time of reporting, the pregnancy was still ongoing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481641

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

gering
Staat
CO
Alter
63,0
Geschlecht
M
Eingang
18.10.2022
Impfdatum
12.10.2022
Beginn
12.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Underdose

Symptomtext

6-11 year old covid iz given to adult.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
dm2,htn,cholesterol,H/A,insomnia
Andere Medikamente
hctz,amlodipine,metformin,humulin,lasoartan,aspirin,atorvastat
Allergien
nkda
Vorherige Impfungen
-

VAERS 2480830

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

gering
Staat
CO
Alter
49,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
12.10.2022
Beginn
13.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

6-11 year old shot given to adult

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
DM,htn,Hypoglycemia
Andere Medikamente
tresiba,,citalopram,,proglitazone ,metformin,simvastatin,panta
Allergien
nkda
Vorherige Impfungen
-

VAERS 2466587

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ888AA

gering
Staat
TX
Alter
16,0
Geschlecht
F
Eingang
01.10.2022
Impfdatum
26.09.2022
Beginn
26.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Medical Assistant inadvertently gave a 16 year old patient the FLUBLOK vaccine thinking the patient was 18 with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 16 years old female patient who was inadvertently administered the INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] vaccine by medical assistant thinking the patient was 18 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 26-Sep-2022, the patient received an unknown dose once of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot: UJ888AA; expiry date 06-Sep-2023; strength: standard; formulation: unknown) via intramuscular route in the left deltoid for prophylactic vaccination (immunization). On 26-Sep-2022, the medical assistant inadvertently gave a 16 year old patient the flublok vaccine thinking the patient was 18 with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2459900

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ888AA

gering
Staat
FL
Alter
55,0
Geschlecht
F
Eingang
25.09.2022
Impfdatum
23.09.2022
Beginn
24.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Anxiety Peripheral swelling Skin warm

Symptomtext

Patient called to report that her arm was a little swollen, and hot to touch, the day after the vaccine. She has had flushots in the past and has never had a problem. It has gone down today, She did not have any pain or a fever at any time. And did not report any hives or itchy skin. She was just a little concerned, I told her that it can happen to some patients. She was putting ice on the area and took Tylenol. I told her to continue to put ice on it and try ibuprofen instead of Tylenol. She will follow up with her doctor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anxiety
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Atorvastatin 10mg , Lisinopril 20mg , Albuterol Inhaler, Clonazepam 0.5mg, Levothyroxine 100mcg
Allergien
-
Vorherige Impfungen
-